Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-22-051955

Options or other derivatives

  • Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Collins Cooper C. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-29 Grant or award : show line 1 in the form Restricted Stock Units +5,000 5,000 D
Loading xslF345X03/doc4.xml…